FDA webpages for Recalls, Market Withdrawals, & Safety Alerts, with link to "Sign up to receive Recalls, Market Withdrawals and Safety Alerts."
MedWatch: The FDA Safety Information and Adverse Event Reporting Program with subscription link
April 21, 2014 — MUMBAI (Reuters) - India's Glenmark Pharmaceuticals Ltd is recalling some 2,900 bottles of its stomach ulcer drug ranitidine [brand name Zantac —ed.] in the United States after a foreign tablet was found in one of the bottles.
The lot being recalled was manufactured for Glenmark by Indian drugmaker Shasun Pharmaceuticals Ltd, and the foreign tablet was identified to be metoprolol tartrate, a drug to treat high blood pressure, according to information posted by the FDA on Thursday. The recall began on March 18.
"Corrective actions have been implemented and the recall is limited to only one lot of material," a Glenmark representative said in a statement to Reuters.
Medicines produced in India [supply] about 40% of generic and over-the-counter drugs sold in the United States, [and] have come under increased scrutiny by the Food and Drug Administration over the past year.
In the last six months alone, products made by some of India's largest drugmakers, including Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd have been recalled from the United States.